Stocksigma LogoStocksigma Logo

Sai Life Sciences Schedules Board Meeting for Q2 and H1 Financial Results

Sai Life Sciences Limited has scheduled a Board of Directors meeting on 5th Nov'26 to consider and approve the standalone and consolidated unaudited

Sai Life Sciences Schedules Board Meeting for Q2 and H1 Financial Results

Sai Life Sciences Ltd 路 Intimation 路 05 Nov 2026, 5:30 am

Sai Life Sciences Schedules Board Meeting for Q2 and H1 Financial Results Sai Life Sciences Limited has scheduled a Board of Directors meeting on 5th Nov'26 to consider and approve the standalone and consolidated unaudited financial results for the second quarter and half year ended 30th Sep'26, alongside other corporate matters. In accordance with insider trading regulations, the trading window for dealing in company securities was closed on 1st Oct'26 and will remain closed until 7th Nov'26 (48 hours post-result announcement) for all designated persons and their immediate relatives.

Original exchange filing (PDF)

More announcements from Sai Life Sciences Ltd

All Sai Life Sciences Ltd announcements